CIC Wealth’s Bristol-Myers Squibb BMY Stock Holding History

CIC Wealth’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,191	Closed	-$204K	–	151
2023 Q2	$204K	Sell	3,191 -200	-6%	-$13.4K	0.07%	153
2023 Q1	$235K	Buy	3,391 +468	+16%	+$33K	0.09%	141
2022 Q4	$210K	Buy	+2,923	New	+$220K	0.09%	156

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

CIC Wealth's BMY Position: Q3 2023 in Review

CIC Wealth sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 3,191 shares — an estimated $204K sold.

CIC Wealth first reported a position in BMY in Q4 2022 and held it in 3 quarters. The position peaked at $235K in Q1 2023. 2,388 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

CIC Wealth reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
CIC Wealth sold 3,191 Bristol-Myers Squibb shares in Q3 2023, an estimated $204K.
CIC Wealth first reported a position in Bristol-Myers Squibb in Q4 2022 and held it in 3 quarters.
CIC Wealth's Bristol-Myers Squibb position peaked at $235K in Q1 2023.
2,388 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on CIC Wealth's 13F filing for Q3 2023, filed 10 Oct 2023.